Some projects, however, have escaped this fate, such as those by biotechnology firms Amplitude and Arcturus. The health ...

Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.1 per share a year ago. These ...

Canva is gaining significant attention as a potential IPO candidate. The rising investor enthusiasm around the design-software giant follows Figma’s (FIG) successful debut. Elevate Your Investing ...